Shuttle Pharmaceuticals Holdings Inc

NAS:SHPH (USA)  
$ 0.74 -0.031 (-4.02%) 11:19 AM EST
At Loss
Volume:
37.36K
Avg Vol (2M):
1.62M
Trade In:
Volume:
37.36K
At Loss
Avg Vol (2M):
1.62M

Business Description

Description
Shuttle Pharmaceuticals Holdings Inc is a clinical stage pharmaceutical company leveraging our proprietary technology to develop novel therapies designed to cure cancers. The company's goal is to extend the benefits of cancer treatments by leveraging insights into the pillars of cancer therapy: surgery, radiation therapy, chemotherapy, and immunotherapy.
Name Current Vs Industry Vs History
Cash-To-Debt 0.28
Equity-to-Asset -1.95
Debt-to-Equity -0.43
Debt-to-EBITDA -0.08
Piotroski F-Score 1/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year EBITDA Growth Rate -72.5
3-Year EPS without NRI Growth Rate -125.4
3-Year FCF Growth Rate -407.2

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 68.16
9-Day RSI 53.88
14-Day RSI 45.45
6-1 Month Momentum % -71.59
12-1 Month Momentum % -75.9

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.22
Quick Ratio 0.22
Cash Ratio 0.09

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -6.6
Shareholder Yield % -0.37
Name Current Vs Industry Vs History
ROE % -385.59
ROA % -212.97
ROIC % -707.7
ROC (Joel Greenblatt) % -2164.34
ROCE % -245.46

GF Value Rank

Name Current Vs Industry Vs History
EV-to-EBIT -0.41
EV-to-EBITDA -0.41
EV-to-FCF -0.53
Earnings Yield (Greenblatt) % -243.9
FCF Yield % -201.66

Financials (Next Earnings Date:2025-03-21 Est.)

SHPH's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:SHPH

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Shuttle Pharmaceuticals Holdings Inc Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $)
EPS (TTM) ($) -4.19
Beta 0
Volatility % 94.63
14-Day RSI 45.45
14-Day ATR ($) 0.093215
20-Day SMA ($) 0.7454
12-1 Month Momentum % -75.9
52-Week Range ($) 0.58 - 4.9464
Shares Outstanding (Mil) 3.66

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 1
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Shuttle Pharmaceuticals Holdings Inc Filings

Filing Date Document Date Form
No Filing Data

Shuttle Pharmaceuticals Holdings Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Shuttle Pharmaceuticals Holdings Inc Frequently Asked Questions

What is Shuttle Pharmaceuticals Holdings Inc(SHPH)'s stock price today?
The current price of SHPH is $0.74. The 52 week high of SHPH is $4.95 and 52 week low is $0.58.
When is next earnings date of Shuttle Pharmaceuticals Holdings Inc(SHPH)?
The next earnings date of Shuttle Pharmaceuticals Holdings Inc(SHPH) is 2025-03-21 Est..
Does Shuttle Pharmaceuticals Holdings Inc(SHPH) pay dividends? If so, how much?
Shuttle Pharmaceuticals Holdings Inc(SHPH) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1